Amex Pharmaceuticals Private Limited
About Amex Pharmaceuticals Private Limited
Data last updated:
Amex Pharmaceuticals Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 02 July 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U85191UP2015PTC071797. Its GSTIN is 09AANCA6002G1ZT (Uttar Pradesh).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Law Tripathi Kush and Sandhya Tripathi.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at S – 15 16/10 Ist Floor Transport Nagar Kanpur Road, Lucknow, Uttar Pradesh, India – 226012.
As per the financials filed for FY 2022, the company reported a revenue of ₹24.33 Lakh, a growth of 32% compared to the previous year. For the same year it recorded a net profit of ₹7,889 (net margin 0.3%) and EBITDA of ₹14,362 (EBITDA margin 0.6%). Revenue has declined at a compounded annual rate (CAGR) of 12% over three years and 2% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Amex Pharmaceuticals Private Limited's registered office is in Lucknow, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressS – 15 16/10 Ist Floor Transport Nagar Kanpur Road, Lucknow, Uttar Pradesh, India – 226012
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Amex Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Amex Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Amex Pharmaceuticals Private Limited, buy the company report.
Financials of Amex Pharmaceuticals Private Limited
FY 2022 filings availableAmex Pharmaceuticals Private Limited reported revenue of ₹24.33 Lakh (up 32% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue rose 32% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 2%. EBITDA fell 31% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹24.33 Lakh | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹14,362 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹7,889 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.6% | ||||
| Net Profit Margin | 0.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Amex Pharmaceuticals Private Limited, buy the company report.
Board of directors of Amex Pharmaceuticals Private Limited
Amex Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Law Tripathi Kush | Director | 02 Jul 2015 | 11 Years 3 Months | Current |
| Sandhya Tripathi | Director | 02 Jul 2015 | 11 Years 3 Months | Current |
Auditor
Amex Pharmaceuticals Private Limited is audited by AMIT SINGHANIA & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AMIT SINGHANIA & CO | FY 2020 | 009145C |
Shareholding
The shareholding of Amex Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Amex Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Amex Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Amex Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Amex Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AANCA6002G1ZT | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Amex Pharmaceuticals Private Limited, buy the company report.
Recent activity
Amex Pharmaceuticals Private Limited has 2 board changes on record since 2015: 2 appointments. The latest: Law Tripathi Kush was appointed as Director on 02 Jul 2015.
Frequently asked questions
Amex Pharmaceuticals is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 02 July 2015 (11+ years old) and is registered under CIN U85191UP2015PTC071797.
Amex Pharmaceuticals has 2 current directors:
- Law Tripathi Kush - Director
- Sandhya Tripathi - Director
The latest financial statements of Amex Pharmaceuticals on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Amex Pharmaceuticals is 09AANCA6002G1ZT, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Amex Pharmaceuticals is U85191UP2015PTC071797. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Amex Pharmaceuticals was incorporated on 02 July 2015, making it 11+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
Law Tripathi Kush was appointed as Director on 02 Jul 2015. Sandhya Tripathi was appointed as Director on 02 Jul 2015.
The registered office of Amex Pharmaceuticals is at S – 15 1610 Ist Floor Transport Nagar Kanpur Road, Lucknow, Uttar Pradesh, India – 226012.
Amex Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Amex Pharmaceuticals is compliant as of 07 September 2026. The company is actively filing with the Registrar of Companies.